D-0250-2018 Class III Terminated

Recalled by G & W Laboratories, Inc. — South Plainfield, NJ

FDA drug recall D-0250-2018 was initiated by G & W Laboratories, Inc. on Jan 19, 2018 and is designated Class III. Reason for recall: Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration. The recall status is terminated (terminated Feb 3, 2020). Affected quantity: 142,236 tubes.

Recall details

Product Type
Drugs
Report Date
Feb 14, 2018
Initiation Date
Jan 19, 2018
Termination Date
Feb 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
142,236 tubes

Product description

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.

Reason for recall

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0250-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0250-2018. Report a data issue: hello@regdatalab.com.